Matthew Disney, PhD, associate professor in the Department of Chemistry at The Scripps Research Institute in Florida, has been working with a talented research team in his lab on a number of projects, including one studying how small molecules may target toxic RNA folds in DM2.
MDF community members often contact the Foundation with questions about genetic testing. We spoke with Carly Siskind of Stanford's Neuromuscular Team about the pros and cons of testing.
Dr. Richard Moxley, Director of the Wellstone Muscular Dystrophy Cooperative Research Center at the University of Rochester and a global leader in DM clinical care and research recently talked with MDF about his long and exceptionally distinguished career in neurology.
Dr. John Day welcomed more than 100 people to the Stanford University School of Medicine's first annual California Myotonic Dystrophy Information Meeting on February 1, 2014.
This past weekend the MDF board of directors and staff met for two days of strategic planning in San Francisco to evaluate the work accomplished in 2013 and identify the project plan and objectives for 2014.